Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle

被引:31
作者
Hamers, C. [1 ]
Galleau, S. [1 ]
Chery, R. [1 ]
Blanchet, M. [1 ]
Besancon, L. [2 ]
Cariou, C. [2 ]
Werle-Lapostolle, B. [2 ]
Hudelet, P. [2 ]
Goutebroze, S. [1 ]
机构
[1] Merial SAS, F-01150 St Vulbas, France
[2] Merial SAS, F-69007 Lyon, France
关键词
NORTHERN EUROPE; CULICOIDES; PROTECTION; PARTICLES; EFFICACY; PROTEINS; VECTOR;
D O I
10.1136/vr.165.13.369
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The immunisation properties of an inactivated bluetongue virus serotype 8 (BTV-8) vaccine were evaluated in sheep and cattle. Five sheep were vaccinated with one dose of vaccine and five cattle were vaccinated with two doses 28 days apart. Six sheep and five cattle served as unvaccinated controls. All animals were subjected to a virulent BTV-8 challenge, and safety and antibody responses were monitored. All control animals developed disease and viraemia, while vaccinated animals were clinically protected and viraemia was completely prevented.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 38 条
[21]   Differentiation between field and vaccine strain of bluetongue virus serotype 16 [J].
Monaco, F. ;
Camma, C. ;
Serini, S. ;
Savini, G. .
VETERINARY MICROBIOLOGY, 2006, 116 (1-3) :45-52
[22]   PHYSICOCHEMICAL AND MORPHOLOGICAL RELATIONSHIPS OF SOME ARTHROPOD-BORNE VIRUSES TO BLUETONGUE VIRUS - NEW TAXONOMIC GROUP - ELECTRON MICROSCOPIC STUDIES [J].
MURPHY, FA ;
BORDEN, EC ;
SHOPE, RE ;
HARRISON, A .
JOURNAL OF GENERAL VIROLOGY, 1971, 13 (NOV) :273-&
[23]  
Patta C, 2004, Vet Ital, V40, P601
[24]  
Roy P, 2004, Vet Ital, V40, P594
[25]   RECOMBINANT VIRUS-VACCINE FOR BLUETONGUE DISEASE IN SHEEP [J].
ROY, P ;
URAKAWA, T ;
VANDIJK, AA ;
ERASMUS, BJ .
JOURNAL OF VIROLOGY, 1990, 64 (05) :1998-2003
[26]   PROTECTIVE EFFICACY OF VIRUS-LIKE PARTICLES FOR BLUETONGUE DISEASE [J].
ROY, P ;
FRENCH, T ;
ERASMUS, BJ .
VACCINE, 1992, 10 (01) :28-32
[27]   LONG-LASTING PROTECTION OF SHEEP AGAINST BLUETONGUE CHALLENGE AFTER VACCINATION WITH VIRUS-LIKE PARTICLES - EVIDENCE FOR HOMOLOGOUS AND PARTIAL HETEROLOGOUS PROTECTION [J].
ROY, P ;
BISHOP, DHL ;
LEBLOIS, H ;
ERASMUS, BJ .
VACCINE, 1994, 12 (09) :805-811
[28]   Bluetongue epidemiology in the European Union [J].
Saegerman, Claude ;
Berkvens, Dirk ;
Mellor, Philip S. .
EMERGING INFECTIOUS DISEASES, 2008, 14 (04) :539-544
[29]   Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle [J].
Savini, G. ;
Hamers, C. ;
Conte, A. ;
Migliaccio, P. ;
Bonfini, B. ;
Teodori, L. ;
Di Ventura, M. ;
Hudelet, P. ;
Schumacher, C. ;
Caporale, V. .
VETERINARY MICROBIOLOGY, 2009, 133 (1-2) :1-8
[30]   Vaccines against bluetongue in Europe [J].
Savini, Giovanni ;
MacLaclalan, N. James ;
Sanchez-Vinaino, Jose-Mantiel ;
Zientara, Stephan .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2008, 31 (2-3) :101-120